EU regulator finds J&J vaccine has ‘possible link’ to blood clots
3 years, 8 months ago

EU regulator finds J&J vaccine has ‘possible link’ to blood clots

Al Jazeera  

The European Union’s medicines regulator on Tuesday said it had found a “possible link” between Johnson & Johnson’s COVID-19 vaccine and the development of rare blood clots in a small number of recipients, but concluded the shot’s overall benefits outweigh any risks associated with its use. The European Medicines Agency said its safety committee decided that a warning about unusual blood clots with low blood platelets must be added to the vaccine’s labels, just as the regulator has also required of rival vaccine maker AstraZeneca, whose own jab was found by the agency last month to also have a “possible link” with rare blood clots. The watchdog also said that most clots among recipients had occurred in the brain and abdomen, as was the case with AstraZeneca’s shot, which is also being studied for similar rare clotting problems. Rare US blood clot cases The EMA’s update came after J&J last week halted the European rollout of its one-dose shot in response to a recommendation by the US Food and Drug Administration that officials pause its use while the rare blood clot cases were examined.

Rare Blood Clots Blood European Astrazeneca Ema Shot Vaccine  covid19  eu  astrazeneca  blood  rare  vaccines  ema  shot  vaccine  link  finds  jj  european  possible  regulator  clots

History of this topic

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
3 months, 3 weeks ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC  

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
6 months, 2 weeks ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 2 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
7 months, 2 weeks ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
7 months, 3 weeks ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect
1 year, 1 month ago

Is AstraZeneca's Covid jab 'defective'? How firm that supplied 50million doses to the UK could face £90million lawsuit over rare blood clot side effect

Daily Mail  

AstraZeneca said jab has 'acceptable safety profile' and regulators state that the benefits outweigh the risks of 'extremely rare potential side-effects' The jabs were dished out 50million times in the UK during the Covid pandemic The AstraZeneca Covid vaccine has been labelled 'defective' in a multi-million-pound lawsuit by patients who suffered a rare side-effect. IT engineer Jamie Scott suffered a …

There’s a new COVID-19 variant. What's JN.1, will vaccines work against it?
1 year, 1 month ago

There’s a new COVID-19 variant. What's JN.1, will vaccines work against it?

Firstpost  

Scientists have detected a new COVID-19 variant, called JN.1, believed to be a descendant of the fast-spreading Pirola strain. Late last week, the United States’ Centers for Disease Control and Prevention flagged a new variant, known as JN.1, in its report, with officials saying they were “learning” about it. Amesh Adalja, MD, a senior scholar at the Johns Hopkins Center …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 1 month ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 1 month ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report
2 years, 7 months ago

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report

Hindustan Times  

Johnson & Johnson’s Covid-19 vaccine was limited to use only in adults for whom other shots aren’t appropriate after an investigation of rare and potentially deadly clotting disorder that occurs in some recipients. J&J’s single-shot vaccine has been noted for its convenience compared to two-shot vaccines, especially in remote areas and in populations like the homeless who may be difficult …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 7 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
2 years, 9 months ago

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients

Daily Mail  

The Johnson & Johnson COVID-19 vaccine was not nearly as effective as its peers at preventing hospitalization from the virus, a new study of elderly patients finds. A French research team found that 28 days after administration of the single-dose J&J shot, and the second dose of the Pfizer-BioNTech vaccine, the J&J recipients were 5.2 times more likely to be …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
2 years, 10 months ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine
3 years ago

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine

Firstpost  

The panel cited the risk of rare but sometimes fatal cases of blood clotting as well as a lower level of effectiveness against COVID-19 in the Johnson & Johnson shot Washington: Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, United States health officials …

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine
3 years ago

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine

Live Mint  

U.S. vaccine advisers are scheduled to consider whether to change recommendations on the use of Johnson & Johnson’s Covid-19 vaccine because of the risk of a rare but serious blood-clotting condition. The Advisory Committee on Immunization Practices will hear updates Thursday from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with …

US CDC panel votes to recommend mRNA COVID-19 vaccines over J&J’s
3 years ago

US CDC panel votes to recommend mRNA COVID-19 vaccines over J&J’s

Al Jazeera  

The US had briefly paused use of the COVID jab in April, before finding benefit outweighs very rare, but deadly, risks. A panel of outside advisers to the US Centers for Disease Control and Prevention has voted to recommend Americans choose to receive one of the other two authorised COVID-19 vaccines over Johnson & Johnson’s shot, due to rare but …

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …

Trigger of rare blood clots linked with AstraZeneca Covid vaccine found
3 years ago

Trigger of rare blood clots linked with AstraZeneca Covid vaccine found

Deccan Chronicle  

Washington: Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease. An international team of researchers investigated vaccine-induced immune thrombotic thrombocytopenia, also known as thrombosis with thrombocytopenia syndrome, a life-threatening condition seen in a very …

European Union Considers Booster Doses of J&J's Covid-19 Vaccine
3 years, 1 month ago

European Union Considers Booster Doses of J&J's Covid-19 Vaccine

News 18  

The European Medicines Agency says it is evaluating whether to authorize booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine. In a statement Monday, the EU drug regulator said it was considering an application from J&J to recommend booster doses of the J&J vaccine for adults 18 and over, at least two months after they were first immunized. The U.S. …

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds
3 years, 1 month ago

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds

Daily Mail  

Johnson & Johnson's COVID-19 vaccine is more than 70 percent effective at preventing infection, a new study finds. However, despite the effectiveness, the team still recommend people to get the Pfizer or Moderna vaccines if possible Researchers found that 0.7% of people vaccinated with the J&J vaccine contracted Covid during the study period, compared to 2.5% of unvaccinated people After …

CDC backs the rollout of COVID vaccine boosters from Moderna and J&J
3 years, 2 months ago

CDC backs the rollout of COVID vaccine boosters from Moderna and J&J

NPR  

CDC backs the rollout of COVID vaccine boosters from Moderna and J&J Enlarge this image toggle caption Michael M. Santiago/Getty Images Michael M. Santiago/Getty Images The Centers for Disease Control and Prevention is backing the roll out of Moderna and Johnson & Johnson COVID-19 vaccine boosters in line with the Food and Drug Administration's authorizations issued Wednesday. A CDC presentation …

FDA panel endorses booster shot for J&J COVID-19 vaccine
3 years, 2 months ago

FDA panel endorses booster shot for J&J COVID-19 vaccine

The Hindu  

U.S. health advisors endorsed a booster of Johnson & Johnson’s COVID-19 vaccine on Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. Unable to settle the best timing, the FDA’s advisory panel voted unanimously that the booster should be offered at least two months after people got their earlier shot. “It …

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters
3 years, 2 months ago

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters

CNN  

CNN — Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend a booster dose of Johnson & Johnson’s vaccine at least two months after people get the first dose. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19-0 to recommend the extra dose for all recipients of the J&J Janssen vaccine, which is …

US coronavirus: With more Covid-19 booster shots on the horizon, one expert says mixing and matching doses may be an effective approach
3 years, 2 months ago

US coronavirus: With more Covid-19 booster shots on the horizon, one expert says mixing and matching doses may be an effective approach

CNN  

CNN — Amid the growing prospect of more Covid-19 booster shots becoming available, an expert has suggested that some people could receive a dose of a different vaccine from the one they initially received. “I hope that when the FDA and CDC review data around Moderna and Johnson & Johnson that they will allow a mix-and-match approach,” CNN medical analyst …

J&J Says Booster Shot Increases Protection to 94% for Moderate-Severe Covid-19
3 years, 3 months ago

J&J Says Booster Shot Increases Protection to 94% for Moderate-Severe Covid-19

News 18  

Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease. President Joe Biden is pushing for booster shots in the face of surging hospitalizations caused by the Delta variant and J&J, the only drugmaker …

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
3 years, 3 months ago

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

CNN  

CNN — A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday – making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s. “Our large real-world-evidence and Phase 3 studies confirm that the single-shot Johnson & Johnson vaccine provides strong and long-lasting protection against …

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month
3 years, 3 months ago

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month

News 18  

US Pharma giant Johnson & Johnson’s single shot vaccine manufactured by Hyderabad-based Biological E is likely to be rolled out by October, News18.com has learnt. The vaccine batches are expected to go for the final testing at the apex laboratories — Central Drugs Laboratory, Kasauli and National Centre for Cell Science, Pune — by next week. “The vaccine is likely …

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa
3 years, 3 months ago

EU to return millions of doses of J&J’s Covid-19 vaccine imported from Africa

Live Mint  

The European Union will return to Africa millions of doses of Johnson & Johnson’s Covid-19 vaccine that it received from a plant in South Africa, following criticism by health activists that the bloc was taking away shots from a continent that has the lowest immunization rate in the world. Strive Masiyiwa, who heads the African Union’s Vaccine Acquisition Task Team, …

South Africa will no longer send J&J vaccines to Europe, AU envoy says
3 years, 3 months ago

South Africa will no longer send J&J vaccines to Europe, AU envoy says

CNN  

CNN — An arrangement in which Johnson & Johnson Covid-19 vaccines were being shipped from South Africa to Europe has been suspended, African Union Special Envoy for Covid-19 response, Strive Masiyiwa, has said. The arrangement was reversed in part due to interventions from South African President Cyril Ramaphosa, European Commission President Ursula von der Leyen, and French President Emmanuel Macron, …

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study
3 years, 3 months ago

Risk of blood clotting after COVID-19 is higher than after getting vaccine, finds UK study

Firstpost  

The study estimated that for 10 million people who received the AstraZeneca jab, there were seven additional cases, compared to 20 in people with Covid infection. Fears over rare cases of clotting conditions have prompted some countries to rule out or limit rollout of the Oxford-developed AstraZeneca jab, with the UK recommending that healthy people under 40 get alternative vaccines. …

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows
3 years, 3 months ago

Blood clot risk from COVID-19 is much higher than from vaccine, U.K. study shows

LA Times  

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer plant in Portage, Mich. COVID-19 patients face a much higher risk of developing blood clots than those vaccinated with the AstraZeneca or Pfizer shots, according to a large U.K. study. For every 10 million people who receive the first dose of AstraZeneca, about 66 more will …

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group
3 years, 4 months ago

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group

The Hindu  

U.S. pharma major Johnson & Johnson has applied for permission to conduct clinical trials of its single-shot COVID-19 vaccine on adolescents aged 12-17 years in India. J&J India spokesperson in a statement said: “We are committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children. On August 17, 2021, we submitted an application …

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents
3 years, 4 months ago

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents

News 18  

Johnson & Johnson on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. “On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged …

J&J Single-dose COVID Vaccine Can Improve Coverage in Tough Terrains, Tackle Inequity
3 years, 4 months ago

J&J Single-dose COVID Vaccine Can Improve Coverage in Tough Terrains, Tackle Inequity

News 18  

Johnson and Johnson or Janssen Pharmaceutica NV’s single-dose COVID-19 vaccine has become the fifth vaccine to receive an emergency use license in India on August 7, 2021. However, as with other viral-vectored vaccines, J&J vaccine has been found to be associated with increased risk of a rare adverse event called thrombosis with thrombocytopenia syndrome. How India Can Optimize Benefits of …

Is J&J Vaccine Effective Against Delta Variant? This African Study Answers in Affirmative
3 years, 4 months ago

Is J&J Vaccine Effective Against Delta Variant? This African Study Answers in Affirmative

News 18  

Data from a clinical trial in South Africa suggests that a single dose of the Covid-19 vaccine made by Johnson & Johnson is highly effective in preventing severe illness and death from the Delta and Beta variants of the coronavirus. As per media reports, the trial evaluated one dose of the Johnson & Johnson vaccine in nearly 500,000 health care …

J&J Vaccine Efficacy & Controversies: What You Need to Know Before Opting for the New Jab
3 years, 4 months ago

J&J Vaccine Efficacy & Controversies: What You Need to Know Before Opting for the New Jab

News 18  

Global healthcare major Johnson & Johnson on Saturday received Emergency Use Authorization for its single-dose COVID-19 vaccine in India, Union Health Minister Mansukh Mandaviya tweeted. Unlike its US counterparts, Moderna and Pfizer vaccines, the Johnson & Johnson vaccine does not use messenger RNA to help the body build its defenses against the virus. Unlike all Indian vaccines, which have to …

Johnson & Johnson gets EUA in India: Here's your ultimate guide to the single-dose vaccine
3 years, 4 months ago

Johnson & Johnson gets EUA in India: Here's your ultimate guide to the single-dose vaccine

Firstpost  

The vaccine was 66.3 percent effective in clinical trials at preventing laboratory-confirmed COVID-19 infection in people who received the vaccine and had no evidence of being previously infected Global healthcare major Johnson & Johnson on Saturday received Emergency Use Authorization for its single-dose COVID-19 vaccine in India, Union Health Minister Mansukh Mandaviya tweeted. The Johnson & Johnson vaccine, known as …

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India
3 years, 4 months ago

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India

Hindustan Times  

Johnson & Johnson, the 134-year-old American pharma conglomerate, has now applied to the Central Drug Standard Control Organisation of India seeking emergency use approval of its single-shot vaccine. Johnson & Johnson has approached the Central Drug Standard Control Organisation for Emergency Use Authorization for the single-dose Covid-19 vaccine "This is an important milestone that paves the way to bringing our …

FDA is letting troubled COVID vaccine factory restart, company says
3 years, 4 months ago

FDA is letting troubled COVID vaccine factory restart, company says

LA Times  

A vial of Johnson & Johnson’s COVID-19 vaccine is used at a pop-up clinic in the Staten Island. The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday. The lapses at the Bayview factory have hampered J&J’s efforts to be a major player in …

COVID-19: Are mix-and-match vaccines the way forward?
3 years, 4 months ago

COVID-19: Are mix-and-match vaccines the way forward?

The Hindu  

A new British study confirms reports that a combination of the AstraZeneca and BioNTech vaccines triggers a stronger immune response than two doses of AstraZeneca. Researchers at the University of Oxford have found that patients who received a dose of AstraZeneca followed by a dose of the BioNTech-Pfizer vaccine four weeks later developed a higher number of antibodies than those …

EXPLAINED: What Is Guillain-Barre Syndrome? Why It's Being Linked To J&J Vaccine
3 years, 5 months ago

EXPLAINED: What Is Guillain-Barre Syndrome? Why It's Being Linked To J&J Vaccine

News 18  

Cases of a rare neurological disorder have emerged in the US among people who were vaccinated with the Covid-19 shot made by Johnson and Johnson, prompting the country’s drug regulator to issue a warning regarding the product. The US Food & Drug Administration has reportedly identified 100 cases of the Guillain-Barre syndrome among people who were vaccinated with the J&J …

FDA adds warning of rare reaction risk to J&J Covid vaccine
3 years, 5 months ago

FDA adds warning of rare reaction risk to J&J Covid vaccine

India TV News  

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem. Health officials described the side effect as a “small possible risk" for those getting the shot.\ The action comes after the FDA and the Centers …

Dangerous trend: WHO warns against mixing and matching Covid vaccines
3 years, 5 months ago

Dangerous trend: WHO warns against mixing and matching Covid vaccines

India Today  

The World Health Organisation's chief scientist on Monday advised against people mixing and matching Covid-19 vaccines from different manufacturers, calling it a "dangerous trend" since there was little data available about the health impact. Infectious disease experts are weighing whether people who received Johnson & Johnson's single-dose vaccine should receive a booster of the Pfizer or Moderna mRNA-based vaccine which …

Pfizer, J&J Anti-Covid-19 Vaccines More Effective Against Delta Than Beta Variant: S African Experts
3 years, 5 months ago

Pfizer, J&J Anti-Covid-19 Vaccines More Effective Against Delta Than Beta Variant: S African Experts

News 18  

The anti-COVID-19 vaccines by US pharma majors Pfizer and Johnson & Johnson that are being used in South Africa are more effective against the Delta variant of the coronavirus than the Beta strain, experts have said. The Beta variant, which was first detected in South Africa, caused a second wave at the beginning of this year whereas the Delta variant, …

Explained: Johnson & Johnson says its COVID-19 vaccine is effective against Delta variant; what this means
3 years, 5 months ago

Explained: Johnson & Johnson says its COVID-19 vaccine is effective against Delta variant; what this means

Firstpost  

J&J has indicated that it is in talks with the Indian government to bring its vaccine to the country of 1.3 billion people Johnson & Johnson ’s vaccine works against the fast-spreading Delta variant and other highly prevalent viral variants of Sars-CoV-2, the virus that causes COVID-19, the company has said. J&J said a study showed the vaccine was 85 …

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant
3 years, 5 months ago

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant

Deccan Chronicle  

New Jersey: Johnson & Johnson on Thursday announced that its single-shot COVID-19 vaccine showed promising signs of protection against the Delta variant rapidly spreading across the US and other countries, in a small laboratory study. "Today's newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally," said Paul Stoffels, …

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find
3 years, 5 months ago

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find

NPR  

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find Enlarge this image toggle caption David Zalubowski/AP David Zalubowski/AP Johnson & Johnson's COVID-19 vaccine offers strong protection against the delta variant of the coronavirus, the company said Thursday. In one small laboratory study, researchers observed what happened to the blood of eight vaccinated individuals when it was …

Discover Related